These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 12438470)

  • 41. Motor deficits associated with Huntington's disease occur in the absence of striatal degeneration in BACHD transgenic mice.
    Mantovani S; Gordon R; Li R; Christie DC; Kumar V; Woodruff TM
    Hum Mol Genet; 2016 May; 25(9):1780-91. PubMed ID: 26908618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
    Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
    J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intraparenchymal striatal transplants required for maintenance of behavioral recovery in an animal model of Huntington's disease.
    Sanberg PR; Giòrdano M; Henault MA; Nash DR; Ragozzino ME; Hagenmeyer-Houser SH
    J Neural Transplant; 1989; 1(1):23-31. PubMed ID: 2535266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stereotactic planning software for human neurotransplantation: suitability in 22 surgical cases of Huntington's disease.
    Lopez WO; Nikkhah G; Schültke E; Furlanetti L; Trippel M
    Restor Neurol Neurosci; 2014; 32(2):259-68. PubMed ID: 24164802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. First step towards cell therapy for Huntington's disease.
    Lindvall O; Björklund A
    Lancet; 2000 Dec; 356(9246):1945-6. PubMed ID: 11130518
    [No Abstract]   [Full Text] [Related]  

  • 46. Striatal volume loss in HD as measured by MRI and the influence of CAG repeat.
    Rosas HD; Goodman J; Chen YI; Jenkins BG; Kennedy DN; Makris N; Patti M; Seidman LJ; Beal MF; Koroshetz WJ
    Neurology; 2001 Sep; 57(6):1025-8. PubMed ID: 11571328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cellular therapy and induced neuronal replacement for Huntington's disease.
    Benraiss A; Goldman SA
    Neurotherapeutics; 2011 Oct; 8(4):577-90. PubMed ID: 21971961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Training specificity, graft development and graft-mediated functional recovery in a rodent model of Huntington's disease.
    Döbrössy MD; Dunnett SB
    Neuroscience; 2005; 132(3):543-52. PubMed ID: 15837116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resting-state functional MRI reveals altered brain connectivity and its correlation with motor dysfunction in a mouse model of Huntington's disease.
    Li Q; Li G; Wu D; Lu H; Hou Z; Ross CA; Yang Y; Zhang J; Duan W
    Sci Rep; 2017 Dec; 7(1):16742. PubMed ID: 29196686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ontogeny of human striatal DARPP-32 neurons in fetuses and following xenografting to the adult rat brain.
    Naimi S; Jeny R; Hantraye P; Peschanski M; Riche D
    Exp Neurol; 1996 Jan; 137(1):15-25. PubMed ID: 8566206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microtransplantation of whole ganglionic eminence cells ameliorates motor deficit, enlarges the volume of grafts, and prolongs survival in a rat model of Huntington's disease.
    Zhu M; Shu K; Wang H; Li X; Xiao Q; Chan W; Emmanuel B; Jiang W; Lei T
    J Neurosci Res; 2013 Dec; 91(12):1563-71. PubMed ID: 24105649
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Protective effect of intrastriatal grafts in an experimental model of Huntington's disease. Behavioral and morphological correlation].
    Levivier M; Pearlman SH; Gash DM; Brotchi J
    Neurochirurgie; 1991; 37(3):148-59. PubMed ID: 1831884
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stereotactic MR imaging for planning neural transplantation: a reliable technique at 3 Tesla?
    Donovan T; Fryer TD; Peña A; Watts C; Carpenter TA; Pickard JD
    Br J Neurosurg; 2003 Oct; 17(5):443-9. PubMed ID: 14635750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurotransmitter distribution in the second trimester fetal human corpus striatum.
    Barami K; Hutchins KD; Lyman WD
    Neurol Res; 2001 Jan; 23(1):16-22. PubMed ID: 11210425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
    Russell DS; Barret O; Jennings DL; Friedman JH; Tamagnan GD; Thomae D; Alagille D; Morley TJ; Papin C; Papapetropoulos S; Waterhouse RN; Seibyl JP; Marek KL
    JAMA Neurol; 2014 Dec; 71(12):1520-8. PubMed ID: 25322077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive Dysfunction in Huntington's Disease: Humans, Mouse Models and Molecular Mechanisms.
    Giralt A; Saavedra A; Alberch J; Pérez-Navarro E
    J Huntingtons Dis; 2012; 1(2):155-73. PubMed ID: 25063329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers.
    Tippett LJ; Waldvogel HJ; Snell RG; Vonsattel JP; Young AB; Faull RLM
    Adv Neurobiol; 2017; 15():129-161. PubMed ID: 28674980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load.
    Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B
    Eur J Neurol; 2008 Nov; 15(11):1180-90. PubMed ID: 18754766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neural transplantation for Huntington's disease: experimental rationale and recommendations for clinical trials.
    Shannon KM; Kordower JH
    Cell Transplant; 1996; 5(2):339-52. PubMed ID: 8689044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.